Assembly Biosciences CEO and President Jason A. Okazaki filed a Form 4 on November 3, 2026, reporting the acquisition of 38,380 shares of common stock through a performance-based restricted stock unit award and the mandatory sale of 6,202 shares to cover tax withholding obligations.
Assembly Biosciences Chief Medical Officer Anuj Gaggar filed a Form 4 on November 3, 2026, disclosing a performance-based restricted stock unit vesting event on October 30, 2026, followed by mandatory sell-to-cover share sales on November 2, 2026.
Director Suzanne M. Coulter of Abercrombie & Fitch Co /DE/ filed a statement of changes in beneficial ownership on November 3, 2026, disclosing the acquisition of phantom stock units on November 2, 2026.
Jeanette M. Bjorkquist, Principal Financial Officer and Principal Accounting Officer of Assembly Biosciences, Inc. (NASDAQ:ASMB), filed a Form 4 on November 3, 2026, disclosing a performance-based restricted stock unit vesting event on October 30, 2026, and two sell-to-cover share sales on November 2, 2026.
Assembly Biosciences Chief Manufacturing Officer Nicole S. White filed a Form 4 on November 3, 2026, disclosing a performance-based restricted stock unit award settlement and mandatory sell-to-cover share sales on October 30 and November 2, 2026.
William E. Delaney IV, Chief Scientific Officer of Assembly Biosciences, Inc., filed a Form 4 on November 3, 2026, disclosing the acquisition of 13,705 shares of common stock on October 30, 2026, following the achievement of a performance-based vesting condition.
Saba Capital Management, L.P. filed a Form 4 with the SEC on November 3, 2026, disclosing a sale of common stock in BlackRock ESG Capital Allocation Term Trust on November 2, 2026.
Jeffrey P. Foster, Chief Legal Officer and Secretary of CubeSmart, filed a Form 4 on November 3, 2026, disclosing a stock option exercise and same-day sale of 22,776 shares of common stock on November 2, 2026.
CubeSmart CFO Timothy M. Martin filed a Form 4 on November 3, 2026, disclosing a same-day option exercise and sale of 36,765 shares of common stock on November 2, 2026.
CarGurus, Inc. Chief Product Officer Ismail Elshareef filed a Form 4 on November 3, 2026, disclosing two transactions in Class A Common Stock on October 30 and November 2, 2026.